Rhythm Pharmaceuticals, Inc

RYTMNASDAQ · Pharmaceutical Preparations

Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

68.8M

on 2026-06-30, from 61.0M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

No limit

S-3ASR of 2026-02-26. An automatic shelf: the form sets no dollar limit. Sales under the at-the-market programme filed with it are not stated apart. S-3ASR ↗

$200.0M

TD Securities (USA), agreement of 2026-02-26. No at-the-market sales statement read from a 10-Q or 10-K. S-3ASR ↗

Warrants

The 10-Q filed 2026-08-04 is not read yet.

Cash

12.6 quarters

$330.9M on 2026-06-30 ÷ $26.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-07-09	Public offering	2,058,824	$85.00	$175.0M	424B5 ↗